Amphastar Pharmaceuticals, Inc.AMPH
| Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
---|
Net income attributable to Amphastar Pharmaceuticals, Inc. | - | - | - | - | -7 | 47 | 1 | 63 | 91 | 138 |
---|
Loss (gain) on disposal of assets | - | - | - | - | - | -1 | -0 | -0 | -0 | -0 |
---|
Gain on deconsolidation of subsidiary | - | - | - | - | - | - | - | 14 | - | - |
---|
Impairment of long-lived assets | - | - | - | - | - | - | - | - | - | 3 |
---|
Gain on interest rate swaps and foreign currency transactions, net | - | - | - | - | - | - | - | - | 2 | -5 |
---|
Gain on deconsolidation of subsidiary | - | - | - | - | - | - | - | 14 | - | - |
---|
Depreciation expense | 13 | 11 | 12 | 13 | 15 | 17 | 20 | 22 | 24 | 25 |
---|
Gain on interest rate swaps and foreign currency transactions, net | - | - | - | - | - | - | - | - | 2 | -5 |
---|
Amortization Of Intangible Assets | 2 | 2 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 13 |
---|
Depreciation expense | 13 | 11 | 12 | 13 | 15 | 17 | 20 | 22 | 24 | 25 |
---|
Operating lease right-of-use asset amortization | - | - | - | - | - | - | - | 3 | 4 | 4 |
---|
Amortization Of Intangible Assets | 2 | 2 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 13 |
---|
Equity in losses of unconsolidated affiliate | - | - | - | - | - | - | - | -0 | -1 | -2 |
---|
Operating lease right-of-use asset amortization | - | - | - | - | - | - | - | 3 | 4 | 4 |
---|
Share-based compensation | 8 | 12 | 15 | 17 | 17 | 17 | 20 | 19 | 18 | 20 |
---|
Amortization of Debt Issuance Costs | - | - | - | - | - | - | - | - | - | 11 |
---|
Changes in reserve for uncertain tax positions | -0 | -0 | 0 | 0 | -0 | 3 | 1 | 2 | 1 | -1 |
---|
Equity in losses of unconsolidated affiliate | - | - | - | - | - | - | - | -0 | -1 | -2 |
---|
Changes in deferred taxes, net | 9 | -8 | 4 | -4 | 1 | -5 | 0 | -2 | 16 | 13 |
---|
Share-based compensation | 8 | 12 | 15 | 17 | 17 | 17 | 20 | 19 | 18 | 20 |
---|
Accounts receivable, net | -1 | 11 | -6 | 8 | 16 | -7 | 20 | 15 | 10 | 26 |
---|
Inventories | -7 | -10 | 10 | -19 | 6 | 41 | -15 | -1 | 12 | 2 |
---|
Prepaid expenses and other assets | 0 | 1 | -1 | 5 | -1 | 4 | 2 | -4 | 2 | 3 |
---|
Income tax refunds, deposits, and payable, net | - | - | - | 12 | -4 | -1 | 1 | -8 | 5 | 3 |
---|
Operating lease liabilities | - | - | - | - | - | -3 | -4 | -3 | -3 | -4 |
---|
Accounts payable and accrued liabilities | 6 | -3 | -1 | 7 | 29 | -12 | 21 | 3 | -1 | 13 |
---|
Changes in reserve for uncertain tax positions | -0 | -0 | 0 | 0 | -0 | 3 | 1 | 2 | 1 | -1 |
---|
Changes in deferred taxes, net | 9 | -8 | 4 | -4 | 1 | -5 | 0 | -2 | 16 | 13 |
---|
Accounts receivable, net | -1 | 11 | -6 | 8 | 16 | -7 | 20 | 15 | 10 | 26 |
---|
Inventories | -7 | -10 | 10 | -19 | 6 | 41 | -15 | -1 | 12 | 2 |
---|
Prepaid expenses and other assets | 0 | 1 | -1 | 5 | -1 | 4 | 2 | -4 | 2 | 3 |
---|
Income tax refunds, deposits, and payable, net | - | - | - | 12 | -4 | -1 | 1 | -8 | 5 | 3 |
---|
Operating lease liabilities | - | - | - | - | - | -3 | -4 | -3 | -3 | -4 |
---|
Accounts payable and accrued liabilities | 6 | -3 | -1 | 7 | 29 | -12 | 21 | 3 | -1 | 13 |
---|
Net cash provided by operating activities | - | - | - | 39 | 38 | 42 | 57 | 98 | 89 | 184 |
---|
Purchases and construction of property, plant, and equipment | 19 | 14 | 21 | 35 | 47 | 42 | 34 | 27 | 24 | 38 |
---|
BAQSIMI acquisition | - | - | - | - | - | - | - | - | - | 506 |
---|
Proceeds from the sale of property, plant and equipment | - | 0 | - | - | 0 | - | - | - | 0 | - |
---|
Purchases and construction of property, plant, and equipment | 19 | 14 | 21 | 35 | 47 | 42 | 34 | 27 | 24 | 38 |
---|
Purchase of investments | - | - | 4 | 6 | 0 | 9 | 14 | 17 | 36 | 145 |
---|
Proceeds from the sale of property, plant and equipment | - | 0 | - | - | 0 | - | - | - | 0 | - |
---|
Maturity of investments | - | - | 3 | 4 | 0 | - | 12 | 19 | 28 | 39 |
---|
Purchase of investments | - | - | 4 | 6 | 0 | 9 | 14 | 17 | 36 | 145 |
---|
Payment of deposits and other assets | - | 1 | 5 | 1 | -0 | 0 | 1 | 3 | 1 | -1 |
---|
Maturity of investments | - | - | 3 | 4 | 0 | - | 12 | 19 | 28 | 39 |
---|
Net cash used in investing activities | - | - | - | -39 | -42 | -51 | -36 | -29 | -33 | -649 |
---|
Deposits and other assets | - | 1 | 5 | 1 | -0 | 0 | 1 | 3 | 1 | -1 |
---|
Net cash used in investing activities | - | - | - | -39 | -42 | -51 | -36 | -29 | -33 | -649 |
---|
Acquisition of additional ownership interest in ANP | - | - | - | - | - | - | 0 | - | - | - |
---|
ANP restructuring (see Note 3) | - | - | - | - | - | - | - | 54 | - | - |
---|
ANP restructuring (see Note 3) | - | - | - | - | - | - | - | 54 | - | - |
---|
Net proceeds from equity plans | - | 14 | 21 | 14 | 9 | 3 | 23 | 16 | 16 | 11 |
---|
Net proceeds from equity plans | - | 14 | 21 | 14 | 9 | 3 | 23 | 16 | 16 | 11 |
---|
Purchase of treasury stock | 0 | 10 | 10 | 31 | 25 | 22 | 24 | 29 | 40 | 58 |
---|
Purchase of treasury stock | 0 | 10 | 10 | 31 | 25 | 22 | 24 | 29 | 40 | 58 |
---|
Settlement Of Equity Awards | - | - | - | - | - | - | - | -1 | - | - |
---|
Settlement Of Equity Awards | - | - | - | - | - | - | - | -1 | - | - |
---|
Debt issuance costs | - | - | - | - | - | - | - | 2 | 0 | 25 |
---|
Debt issuance costs | - | - | - | - | - | - | - | 2 | 0 | 25 |
---|
Repayments under lines of credit | 40 | - | - | - | - | 0 | - | 1 | - | - |
---|
Proceeds from borrowing under lines of credit | 25 | - | - | - | 0 | - | 1 | - | - | - |
---|
Proceeds from issuance of long-term debt | 27 | 7 | 10 | 19 | 8 | 4 | 6 | 70 | - | 845 |
---|
Repayments under lines of credit | 40 | - | - | - | - | 0 | - | 1 | - | - |
---|
Principal payments on long-term debt | 8 | 9 | 15 | 10 | 6 | 6 | 8 | 37 | 2 | 319 |
---|
Proceeds from issuance of long-term debt | 27 | 7 | 10 | 19 | 8 | 4 | 6 | 70 | - | 845 |
---|
Net cash provided by financing activities | - | - | - | -8 | 25 | -4 | -2 | -37 | -26 | 454 |
---|
Principal payments on long-term debt | 8 | 9 | 15 | 10 | 6 | 6 | 8 | 37 | 2 | 319 |
---|
Net cash provided by financing activities | - | - | - | -8 | 25 | -4 | -2 | -37 | -26 | 454 |
---|
Effect of exchange rate changes on cash | - | - | - | - | - | -0 | 0 | -0 | -0 | -0 |
---|
Net (decrease) increase in cash, cash equivalents, and restricted cash | - | - | - | - | - | -13 | 19 | 32 | 30 | -12 |
---|
Capital Expenditures Incurred but Not yet Paid | - | - | - | - | - | 11 | 11 | 9 | 5 | 4 |
---|
Deferred Payment For Acquisition | - | - | - | - | - | - | - | - | - | 122 |
---|
Noncash Operating Lease Right Of Use Asset | - | - | - | - | - | 8 | 5 | 11 | 2 | 11 |
---|
Capital Expenditures Incurred but Not yet Paid | - | - | - | - | - | 11 | 11 | 9 | 5 | 4 |
---|
Equipment acquired under finance leases | 0 | 0 | 1 | - | 0 | 0 | 0 | 0 | 1 | - |
---|
Noncash Operating Lease Right Of Use Asset | - | - | - | - | - | 8 | 5 | 11 | 2 | 11 |
---|
Equipment acquired under finance leases | 0 | 0 | 1 | - | 0 | 0 | 0 | 0 | 1 | - |
---|
Interest paid, net of capitalized interest | - | - | - | 2 | 2 | 2 | 2 | 2 | 3 | 18 |
---|
Income taxes paid | 0 | 0 | 3 | 5 | 0 | 6 | 3 | 8 | 44 | 49 |
---|